FOSTER CITY, CA, USA I February 18, 2025 I Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions ...
INCHEON, South Korea I 18, 2025 I Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈